Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides

Area of Science:

• Biochemistry
• Bioinformatics
• Drug Discovery

Background:

• Hemolytic activity in peptides is a critical factor in therapeutic peptide design.
• Existing databases lack comprehensive, curated data on peptide hemolytic activity.
• Accurate prediction and analysis of hemolytic properties are essential for peptide drug development.

Purpose of the Study:

• To introduce Hemolytik, a manually curated database of experimentally determined hemolytic and non-hemolytic peptides.
• To provide a centralized resource for researchers involved in designing therapeutic peptides.
• To facilitate data searching and analysis through a user-friendly interface.

Main Methods:

• Data compilation from published literature and existing peptide databases (e.g., Antimicrobial Peptide Database, Swiss-Prot).
• Inclusion of experimentally determined hemolytic activity on erythrocytes from 17 different sources.
• Tertiary structure prediction and secondary structure assignment for each peptide entry.

Main Results:

• The Hemolytik database contains approximately 3000 entries, including over 2000 unique peptides.
• Each entry provides comprehensive peptide information: sequence, origin, function, properties, and hemolytic activity details.
• A user-friendly interface with data searching and analysis tools has been developed.

Conclusions:

• Hemolytik offers a valuable, curated resource for studying peptide hemolytic activity.
• The database supports researchers in the rational design of safer and more effective therapeutic peptides.
• The integrated tools enhance accessibility and utility for the scientific community.